Seasonal influenza vaccination among cancer patients: A systematic review and meta-analysis of the determinants |
| |
| Authors: | George N Okoli Otto LT Lam Tiba Abdulwahid Christine J Neilson Salaheddin M Mahmud Ahmed M Abou-Setta |
| |
| Institution: | 1. College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, MB, Canada;2. Vaccine and Drug Evaluation Centre, University of Manitoba, MB, Canada;3. George & Fay Yee Centre for Healthcare Innovation, University of Manitoba, MB, Canada;4. Neil John Maclean Health Sciences Library, University of Manitoba, MB, Canada;5. Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, MB, Canada;1. Division of Dermatology, IRCCS Policlinico di Sant''Orsola, via Massarenti 9, 40138 Bologna, Italy;2. Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40138 Bologna, Italy;3. Division of Oncology, IRCCS Policlinico di Sant''Orsola, via Massarenti 9, 40138 Bologna, Italy;1. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, 270 Dongan Rd, Shanghai 200032, China.;2. Department of Medical Oncology, Suzhou Municipal Hospital, Affiliated Suzhou Hospital of Nanjing Medical University, 16 Baita Road West, Suzhou, Jiangsu Province, 215001, China;3. Department of Oncology, The First Affiliated Hospital of Fujian Medical University Fuzhou, China;1. Department of Oncology, Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;2. Department of Neurology, Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;3. Department of Neurosurgery, Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;4. Intensive care department, Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;5. Department of Pathology, Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal;1. Department of Internal Medicine, SMG-Seoul National University Boramae Medical Center, Seoul, South Korea;2. Department of Radiation Oncology, SMG-Seoul National University Boramae Medical Center, Seoul, South Korea;3. Department of Radiology, SMG-Seoul National University Boramae Medical Center, Seoul, South Korea;1. Department of General Surgery, Tongji Hospital, Medical School of Tongji University, Shanghai, PR China;2. Department of General Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou, PR China;3. Department of General Surgery, The First Affiliated Hospital of Xingjiang Medical University, Urumqi, Xinjiang Province, PR China;4. Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China;5. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, PR China;6. School of Clinical Medicine, Dali University, Dali, Yunnan 671000, PR China;7. Yizheng People''s Hospital, Clinical Medical College, Yangzhou University, Yangzhou 211400, Jiangsu Province, China;8. Changzhi People''s Hospital, The Affiliated Hospital of Changzhi Medical College, Changzhi 046000, Shanxi Province, China;1. Department of Obstetrics & Gynecology and Women''s Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA;2. Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women''s Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA;3. Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York, USA |
| |
| Abstract: | Cancer patients are among high-risk individuals for whom seasonal influenza vaccine (SIV) is recommended, but rates of vaccination in this subpopulation remain suboptimal; even in jurisdictions with universal influenza vaccination programs. We sought to summarize the evidence to better understand the determinants of SIV uptake (vaccine receipt) among cancer patients. We searched MEDLINE, Embase, and CINAHL from 2000 to February 12, 2020, focusing on articles on the determinants of seasonal influenza vaccination among cancer patients, published in English. Study selection was conducted independently by 2 reviewers. One reviewer extracted data from the included studies and another reviewer checked the extracted data for errors. Outcomes were sociodemographic and health-related factors. We pooled adjusted results from studies using the inverse variance, random-effects method, and reported the odds ratios (OR) and their 95% confidence intervals (CI). Out of 2664 citations, 10 studies (mostly from USA and South Korea) met our eligibility criteria. Overall, being older (OR 2.23, 95% CI 1.46-3.38; I2 92.3%, 6 studies]), a nonsmoker (1.43, 1.32-1.51; I2 0%, 4 studies]), having a chronic illness (1.18, 1.07-1.29; I2 15.7%, 5 studies]), having had a medical check-up in the past year (1.75, 1.65-1.86; I2 0%, 2 studies]), and having health insurance (1.39, 1.13-1.72; I2 21.8%, 3 studies]) were associated with increased SIV uptake. Compared with being African-American, being Caucasian was also associated with increased SIV uptake (1.79, 1.47-2.13; I2 10.7%, 3 studies]). Limited evidence suggests seasonal influenza vaccination among cancer patients may be determined by some sociodemographic and health-related factors. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
